Screener
LeMaitre Vascular LMAT Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from LeMaitre Vascular’s reported figures.
The source filing: LeMaitre Vascular’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333762
| Line item | Three months ended / June 30, 2026 | Three months ended / June 30, 2025 | Six months ended / June 30, 2026 | Six months ended / June 30, 2025 |
|---|---|---|---|---|
| Net sales | $70,382 | $64,232 | $136,933 | $124,103 |
| Cost of sales | 19,618 | 19,258 | 37,773 | 37,709 |
| Gross profit | 50,764 | 44,974 | 99,160 | 86,394 |
| Sales and marketing | 14,408 | 14,895 | 28,923 | 29,107 |
| General and administrative | 11,110 | 10,396 | 23,156 | 20,883 |
| Research and development | 4,847 | 3,541 | 8,907 | 7,636 |
| Total operating expenses | 30,365 | 28,832 | 60,986 | 57,626 |
| Income from operations | 20,399 | 16,142 | 38,174 | 28,768 |
Item 1. Financial Statements
FAQ
- What is LeMaitre Vascular's gross profit?
- LeMaitre Vascular (LMAT) reported gross profit of $50.76M in Q2 2026.
- How has LeMaitre Vascular's gross profit changed year-over-year?
- LeMaitre Vascular's gross profit increased by 12.9% year-over-year, from $44.97M to $50.76M.
- What is the long-term trend for LeMaitre Vascular's gross profit?
- Over 4 years (2021 to 2025), LeMaitre Vascular's gross profit has grown at a 15.2% compound annual growth rate (CAGR), from $101.38M to $178.54M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about LeMaitre Vascular's gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude